Services - 383861-2021

28/07/2021    S144

Spain-Barcelona: Research and experimental development services

2021/S 144-383861


Notice for changes or additional information


(Supplement to the Official Journal of the European Union, 2021/S 141-374082)

Legal Basis:
Directive 2014/24/EU

Section I: Contracting authority/entity

I.1)Name and addresses
Official name: Fundación de Gestión Sanitaria del Hospital de la Santa Creu i Sant Pau
National registration number: G59780494
Postal address: Sant Antoni M. Claret, 167 - Pabellón Sant Antoni planta baja
Town: Barcelona
NUTS code: ES511 Barcelona
Postal code: 08025
Country: Spain
Contact person: Unidad de Contratación
Telephone: +34 935537621
Fax: +34 935537631
Internet address(es):
Main address:
Address of the buyer profile:
I.1)Name and addresses
Official name: Azienda Sanitaria Locale Avellino
National registration number: IT 02600160648
Postal address: Via degli Imbimbo, 10/12
Town: Avellino
NUTS code: ITF34 Avellino
Postal code: 831000
Country: Italy
Contact person: Anna Marro
Internet address(es):
Main address:
I.1)Name and addresses
Official name: Region Västerbotten
National registration number: SE 894000-9437
Postal address: Region Västerbotten, 901 89 Umeå
Town: Umeå
NUTS code: SE331 Västerbottens län
Postal code: 901 89
Country: Sweden
Contact person: Andreas Lundqvist
Internet address(es):
Main address:

Section II: Object

II.1)Scope of the procurement

Pre-Commercial Procurement to buy R&D (Research and Development) Services to Deliver Quick Responses for Individuals with Advanced Heart Failure and Complex Care Needs through Integrated Care (TIQUE)

II.1.2)Main CPV code
73100000 Research and experimental development services
II.1.3)Type of contract
II.1.4)Short description:

This PIN provides early information about the expected starting date and purchase volume for a pre-commercial procurement (PCP) and about the open market consultation (OMC) that is organised in preparation of this procurement. See sections II.2.4 and II.2.14 for details.

The procurement aims to trigger new solutions to be developed and tested to address the following challenge: improve treatment for patients with advanced heart failure and complex care needs through technology enabled integrated care solutions.

The main target improvements are: 33 % increase of patient life expectancy, 40 % reduction of acute hospital admissions, 20 % reduction of drug-related health problems, 20 % increase of home care attention and 10 % increase of end-of-life care at home.

This PCP procurement is a joint procurement by different procurers across Europe that are all facing the same common challenge and are thus looking for similar solutions (so-called ‘buyers group’).

Section VI: Complementary information

VI.5)Date of dispatch of this notice:
VI.6)Original notice reference
Notice number in the OJ S: 2021/S 141-374082

Section VII: Changes

VII.1)Information to be changed or added
VII.1.2)Text to be corrected in the original notice
Section number: II.2.4)
Place of text to be modified: Description of the procurement:
Instead of:
Section number: II.2.14)
Place of text to be modified: Additional information
Instead of:
Section number: VI.3)
Place of text to be modified: Additional information:
Instead of:
VII.2)Other additional information: